CClinicalTrials.gg
CompletedNCT03810781Updated Dec 15, 2025Results posted

Postural Stability in Cervical Spinal Myelopathy

An observational study in Cervical Spondylotic Myelopathy, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-15.

Sponsored by VA Office of Research and Development · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
8
Ages
18 Years and older
Sex
All
01

Study summary

Veterans are at heightened risk of developing cervical spondylotic myelopathy (CSM) from rigors of military service. Balance and posturography are negatively affected in CSM, but require expensive equipment, and extensive training of personnel for data acquisition and interpretation. The Virtual Environment TBI Screen (VETS) is a simple and inexpensive construct that could be implemented as an aid in diagnosis and as an objective means to compare treatment modalities and track recovery. The goal for the SPiRE is to generate the critical data to support rigorous Merit studies of posturography for assessments of clinical course in the treatment and rehabilitation of CSM. The investigators' ultimate goal, if the SPiRE is successful, is to phase in objective posturography assessments as VA standard of care in CSM.

Read the detailed description

COVID-19 administrative hold

Veterans are at heightened risk of developing cervical spondylotic myelopathy (CSM) from rigors of military service. Diagnosis of CSM involves a set of clinical findings and is confirmed by imaging the spine.

Gait impairment and disturbances of stance control are hallmarks of CSM and are a consequence of abnormalities in proprioception due to dorsal column tract damage of the spine. Currently, gait and balance deficits rely on clinical level assessments and judgement for detection. An objective measure of posturography has the benefit of: a) quantifying balance-related disability in CSM, b) facilitating structure-functional assessments in CSM, and c) quantifying the degree surgical interventions affect posturography and recovery of function in CSM.

Objective and sensitive means for assessing balance and posturography exist, but are not routinely incorporated in diagnosis or functional tracking of progress after interventions such as surgery. A barrier may be accessibility of posturography and ease of assessments. The Virtual Environment TBI Screen (VETS) was devised using Army Rapid Innovation Development funding to objectively assess balance and posturography in a cost effective, but sensitive manner. VETS involves virtual environments and computerized posturography and is proving to be a sensitive system facilitating diagnosis, treatment, and mitigation of balance dysfunction associated with mTBI.

The working hypothesis is VETS testing will enhance clinical judgements regarding CSM. The SPiRE is designed to provide data critical to a more extensive program of research incorporating posturography into treatment and rehabilitation of CSM.

First, a limited comparative study of standing balance will be conducted of 20 Veterans being evaluated for cervical spine surgery to treat CSM and 20 otherwise healthy Veterans. Second, posturography of the Veterans undergoing surgery to treat CSM will be tracked during their scheduled follow up visits to determine the degree VETS scores are affected by surgery and to track recovery from CSM.

Patients in the CSM group will be selected based on clinical criteria. Veterans in the control group will be recruited from the Syracuse Veterans Affairs Medical Center (SVAMC) and surrounding community.

For VETS testing, the Veteran will stand directly on a firm surface or foam pad placed on top of a Wii Balance Board (WBB). There are six conditions manipulating surface (firm or foam surface) and visual input (eyes open viewing a static scene, eyes closed, and eyes open viewing a dynamic visual scene). The primary measure is the center of pressure (COP) sway area. These 6 conditions allow for an assessment of generalized vs specific deficits in COP sway area considering proprioception, dependence of visual input and visuo-proprioceptive integration.

AIM 1A: Determine whether and to what degree balance is altered in CSM. The degree of COP sway will be compared between CSM and controls in the six conditions comprising VETS testing.

AIM 1B: Determine whether VETS enhances sensitivity and selectivity in the diagnosis of CSM. Composite measures of balance will be related to clinical assessment tools and their relationship with MRI.

AIM 2: Evaluate the VETS scores after surgery to treat CSM. The degree of COP sway area under the 6 conditions will be compared before surgery, 2 weeks, 6 weeks and 6 months after surgery (corresponding with post-operative clinical assessments).

The ultimate goal is to validate and incorporate objective balance testing into routine assessment for CSM to aid in disambiguating CSM, to improve functional assessments of recovery, and to aid in evaluations of different treatment and rehabilitation strategies in CSM for the Veteran population.

02

Conditions studied

  • Cervical Spondylotic Myelopathy

Keywords

  • Posturography
  • Spinal Cord Injury
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 8 is below the median of 60 across 323 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

US Veterans.

Eligibility criteria

Inclusion Criteria:

Patients in the CSM group will be selected based on clinical criteria. Inclusion criteria for the CSM group are:

  • symptoms of myelopathy in upper and lower extremities and stenosis of the cervical spine demonstrated by MRI or myelography
  • lower extremity muscle strength of 4 as quantified by manual muscle test (MMT) 36 or above
  • ability to stand without support with eyes closed for 30 s or more
  • Veterans in the control group will be recruited from the SVAMC and surrounding community using printed advertisements

Exclusion Criteria:

Exclusion criteria for all study participants are:

  • presence of lower extremity or lumbar spine disease
  • peripheral neuropathy
  • history of other neurological disorder
  • inability to stand in an upright position with both feet together and eyes closed
  • Although the SVAMC population is predominately Caucasian and male, every effort will be made to recruit minorities and women
  • The proposed study will neither target for recruitment nor will the investigators exclude pregnant women
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
8 participants (actual)
Patient registry
No

Groups and cohorts

  • Cervical Spondylotic Myelopathy (CSM)

    Degenerative cervical myelopathy, encapsulates a cascade of events leading to significant degenerative changes in discs, formation of osteophytes, facet hypertrophy, calcification of the posterior longitudinal ligament and ligamentous flavum with resultant canal stenosis and segmental instability.

06

What researchers measure

Primary outcomes

  1. Virtual Environment TBI System (VETS) Assessment of Static Posturography

    The postural stability task involves six conditions during which Veterans are instructed to look straight ahead and maintain an upright stance as stably as possible. Veterans are barefooted with feet comfortably placed \~25 cm apart. The six conditions are (1) Eyes Open (EO) Firm (2) Eyes Closed (EC) Firm, (3) Dynamic Scene (DYN) Firm, (4) EO Foam, (5) EC Foam, and (6) DYN Foam. a) Comparison of CSM vs. Control and within-subject visual (EO,EC, and DYN) and surface conditions (FIRM and FOAM). b) Comparison of balance and posture at Pre-surgery for CSM group to age and gender matched non-CSM controls. Only pre-surgery data in CSM group was collected due to COVID-19.

    Time frame: Pre-Surgery compared to otherwise healthy Veterans

  2. Change in Static Posturography (VETS)

    The Pre-surgery CSM group recruited for VETS (Static Posturography) measurement will also serve as the sample for the change in VETS measurement as a change in centimeters (cm). This is a longitudinal assessment of balance following surgical intervention for CSM.

    Time frame: Pre-surgery compared to 2 weeks, 6 weeks, and 6 months post-surgery VETS factors. The Post-surgery endpoints are normally scheduled clinical follow ups.

Secondary outcomes

  1. Nurick Scale

    The Nurick scale is a 6-grade ordinal scale assessing gait impairment, with grades ranging from 0 (signs and symptoms of root involvement but no evidence of spinal cord disease) to 5 (chair bound or bedridden). The aggregate value of the Nurick scale will be related to posturography. Classification Scheme: * Grade 0: signs or symptoms of root involvement but without evidence of spinal cord disease * Grade 1: signs of spinal cord disease but no difficulty in walking. * Grade 2: slight difficulty in walking which does not prevent full-time employment * Grade 3: difficulty in walking which prevented full time employment or the ability to do all housework, but which was not so severe as to require someone else's help to walk * Grade 4: able to walk only with someone else's help or with the aid of a frame. * Grade 5 : chairbound or bedridden.

    Time frame: PreSurgery compared to otherwise healthy Veterans

  2. Neck Disability Index (NDI)

    NDI is related to VETS posturography to determine sensitivity of standing posture to degree of disability. The NDI is a 10-item questionnaire addressing function activities (personal care, lifting, reading, work, driving, sleeping, and recreation), pain intensity, concentration, and headache. For each item, patients make their ratings on a 6-point Likert scale with values 0 = no disability and 5 = complete disability. Summed scores for each category are multiplied by 2 to give a total NDI score ranging from 0-100. Score: /50 Transform to percentage score x 100 = %points. Scoring: Example:16 (total scored)50 (total possible score) x 100 = 32% If one section is missed or not applicable the score is calculated: 16 (total scored)45 (total possible score) x 100 = 35.5% Minimum Detectable Change (90% confidence): 5 points or 10 %points

    Time frame: PreSurgery compared to otherwise healthy Veterans

  3. Short Form-36 Version 2 (SF-36v2)

    The SF-36 questionnaire consists of eight scales yielding two summary measures: physical and mental health. The physical health measure includes four scales of physical functioning (10 items), role-physical (4 items), bodily pain (2 items), and general health (5 items). The mental health measure is composed of vitality (4 items), social functioning (2 items), role-emotional (3 items), and mental health (5 items). The SF-36 offers a choice of recall format at a standard (4 week) or acute (1 week) time frame. Likert scales and yes/no options are used to assess function and well-being on this 36-item questionnaire. To score the SF-36, scales are standardized with a scoring algorithm or by the SF-36v2 scoring software to obtain a score ranging from 0 to 100. Higher scores indicate better health status, and a mean score of 50 has been articulated as a normative value for all scales.

    Time frame: PreSurgery compared to otherwise healthy Veterans

  4. EC FIRM/EO FIRM Ratio

    From the VETS, a ratio corresponding to the Rhomberg ratio of COP sway will be used to determine the degree static posture depends on visual input. The Romberg test used in posturography compares postural sway in eyes open (EO) and eyes closed (EC) conditions. The Romberg ratio was calculated in the traditional manner, i.e. EC/EO. The ensuing Romberg ratio (EC/EO) is used to assess visual dependency in postural stability. Higher Romberg ratios reflect greater instability with closed eyes, ( a greater amount of postural sway during eyes closed) whereas a ratio \< 1 indicates higher stability in the EC versus EO condition.

    Time frame: PreSurgery

  5. EO FOAM/EO FIRM

    From the VETS, a ratio of COP sway will be used to determine the degree static posture is affected by reduced proprioception.

    Time frame: PreSurgery compared to otherwise healthy Veterans

  6. EC FOAM/EO FOAM Ratio

    From the VETS, a ratio of COP sway will be used to determine the degree of loss of visual information. Loss of visual information compounds reduced proprioceptive ability in static balance.

    Time frame: PreSurgery compared to otherwise healthy Veterans

  7. DYN FOAM/DYN FIRM Ratio

    From the VETS, a ratio of COP sway will be used to determine how roll vection is induced by loss of proprioception.

    Time frame: PostSurgery compared to otherwise healthy Veterans compared to otherwise healthy Veterans

  8. DYN FIRM/ EO FIRM Ratio

    From the VETS, a ration of COP sway to determine the degree roll vection is induced.

    Time frame: PreSurgery compared to otherwise healthy Veterans

07

Results

Posted Dec 15, 2025
Limitations and caveats
COVID significantly disrupted our ability to complete the study. Scheduling for CSM surgery was drastically impacted by COVID and never returned to Pre-COVID format. Some subjects recruited before COVID could not be followed up due to a ban on research. We were also unable to recruit controls because our VA only permitted research appointments for individuals who were already coming to the VA for a medical appointment (e.g. surgical follow-up).

Participant flow

Recruitment was significantly hampered by COVID-19 and research shut-downs. Myelopathy surgeries were significantly limited because of COVID as well. Participants were recruited from the pool of eligible individuals undergoing surgery for myelopathy in the Syracuse VA. Recruitment occurred between 2/7/19 and 7/26/22

Participant flow — Overall Study
MilestoneCervical Spondylotic Myelopathy (CSM)
Started8
Completed6
Not completed2
Withdrew: Covid shut down2

Outcome measures

PrimaryVirtual Environment TBI System (VETS) Assessment of Static Posturography

The postural stability task involves six conditions during which Veterans are instructed to look straight ahead and maintain an upright stance as stably as possible. Veterans are barefooted with feet comfortably placed \~25 cm apart. The six conditions are (1) Eyes Open (EO) Firm (2) Eyes Closed (EC) Firm, (3) Dynamic Scene (DYN) Firm, (4) EO Foam, (5) EC Foam, and (6) DYN Foam. a) Comparison of CSM vs. Control and within-subject visual (EO,EC, and DYN) and surface conditions (FIRM and FOAM). b) Comparison of balance and posture at Pre-surgery for CSM group to age and gender matched non-CSM controls. Only pre-surgery data in CSM group was collected due to COVID-19.

Time frame:
Pre-Surgery compared to otherwise healthy Veterans
Reported as:
Mean · Square Centimeters
Virtual Environment TBI System (VETS) Assessment of Static Posturography
Square CentimetersPre-surgical Group: Cervical Spondylotic Myelopathy (CSM)Healthy Controls
EO Firm11 ± 27.1—
EC Firm13.0 ± 15.4—
DYN Firm48.4 ± 51.1—
EO Foam19.1 ± 20.3—
EC Foam44 ± 32.7—
DYN Foam70.7 ± 47.7—
PrimaryChange in Static Posturography (VETS)

The Pre-surgery CSM group recruited for VETS (Static Posturography) measurement will also serve as the sample for the change in VETS measurement as a change in centimeters (cm). This is a longitudinal assessment of balance following surgical intervention for CSM.

Time frame:
Pre-surgery compared to 2 weeks, 6 weeks, and 6 months post-surgery VETS factors. The Post-surgery endpoints are normally scheduled clinical follow ups.
Reported as:
Mean · CM
Change in Static Posturography (VETS)
CMCervical Spondylotic Myelopathy (CSM) Group
EO Firm PreOp11 ± 27.1
EC Firm PreOp13 ± 15.4
DYN Firm PreOp48.4 ± 51.1
EO Foam PreOp19.1 ± 20.3
EC Foam PreOp44 ± 32.7
DYN Foam PreOp70.7 ± 47.7
EO Firm 2Weeks5.6 ± 4.3
EC Firm 2Weeks9.4 ± 8.5
DYN Firm 2Weeks11.2 ± 7
EO Foam 2Weeks9.8 ± 7
EC Foam 2Weeks44.3 ± 28.7
DYN Foam 2Weeks63.5 ± 39.6
EO Firm 6Weeks7.2 ± 9.8
EC Firm 6Weeks15.6 ± 22.1
DYN Firm 6Weeks15.4 ± 15.1
EO Foam 6Weeks12.2 ± 7.5
EC Foam 6Weeks37.6 ± 31
DYN Foam 6Weeks88.5 ± 68.7
EO Firm 6Months5 ± 5.4
EC Firm 6Months12 ± 15.1
DYN Firm 6Months24.7 ± 33.8
EO Foam 6Months13.5 ± 6.1
EC Foam 6Months41.4 ± 19.1
DYN Foam 6Months62.9 ± 38.1
SecondaryNurick Scale

The Nurick scale is a 6-grade ordinal scale assessing gait impairment, with grades ranging from 0 (signs and symptoms of root involvement but no evidence of spinal cord disease) to 5 (chair bound or bedridden). The aggregate value of the Nurick scale will be related to posturography. Classification Scheme: * Grade 0: signs or symptoms of root involvement but without evidence of spinal cord disease * Grade 1: signs of spinal cord disease but no difficulty in walking. * Grade 2: slight difficulty in walking which does not prevent full-time employment * Grade 3: difficulty in walking which prevented full time employment or the ability to do all housework, but which was not so severe as to require someone else's help to walk * Grade 4: able to walk only with someone else's help or with the aid of a frame. * Grade 5 : chairbound or bedridden.

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · Units on a scale
Nurick Scale
Units on a scaleCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
Nurick Scale2 ± .89—
SecondaryNeck Disability Index (NDI)

NDI is related to VETS posturography to determine sensitivity of standing posture to degree of disability. The NDI is a 10-item questionnaire addressing function activities (personal care, lifting, reading, work, driving, sleeping, and recreation), pain intensity, concentration, and headache. For each item, patients make their ratings on a 6-point Likert scale with values 0 = no disability and 5 = complete disability. Summed scores for each category are multiplied by 2 to give a total NDI score ranging from 0-100. Score: /50 Transform to percentage score x 100 = %points. Scoring: Example:16 (total scored)50 (total possible score) x 100 = 32% If one section is missed or not applicable the score is calculated: 16 (total scored)45 (total possible score) x 100 = 35.5% Minimum Detectable Change (90% confidence): 5 points or 10 %points

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · Units on a scale
Neck Disability Index (NDI)
Units on a scaleCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
Neck Disability Index (NDI)59.5 ± 17.5—
SecondaryShort Form-36 Version 2 (SF-36v2)

The SF-36 questionnaire consists of eight scales yielding two summary measures: physical and mental health. The physical health measure includes four scales of physical functioning (10 items), role-physical (4 items), bodily pain (2 items), and general health (5 items). The mental health measure is composed of vitality (4 items), social functioning (2 items), role-emotional (3 items), and mental health (5 items). The SF-36 offers a choice of recall format at a standard (4 week) or acute (1 week) time frame. Likert scales and yes/no options are used to assess function and well-being on this 36-item questionnaire. To score the SF-36, scales are standardized with a scoring algorithm or by the SF-36v2 scoring software to obtain a score ranging from 0 to 100. Higher scores indicate better health status, and a mean score of 50 has been articulated as a normative value for all scales.

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · Units on a scale
Short Form-36 Version 2 (SF-36v2)
Units on a scaleCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
Short Form-36 Version 2 (SF-36v2)44.1 ± 21.1—
SecondaryEC FIRM/EO FIRM Ratio

From the VETS, a ratio corresponding to the Rhomberg ratio of COP sway will be used to determine the degree static posture depends on visual input. The Romberg test used in posturography compares postural sway in eyes open (EO) and eyes closed (EC) conditions. The Romberg ratio was calculated in the traditional manner, i.e. EC/EO. The ensuing Romberg ratio (EC/EO) is used to assess visual dependency in postural stability. Higher Romberg ratios reflect greater instability with closed eyes, ( a greater amount of postural sway during eyes closed) whereas a ratio \< 1 indicates higher stability in the EC versus EO condition.

Time frame:
PreSurgery
Reported as:
Mean · COP sway ratio
EC FIRM/EO FIRM Ratio
COP sway ratioCervical Spondylotic Myelopathy (CSM) Group
EC FIRM/EO FIRM Ratio1.56 ± 1.03
SecondaryEO FOAM/EO FIRM

From the VETS, a ratio of COP sway will be used to determine the degree static posture is affected by reduced proprioception.

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · COP sway ratio
EO FOAM/EO FIRM
COP sway ratioCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
EO FOAM/EO FIRM2.92 ± 3.17—
SecondaryEC FOAM/EO FOAM Ratio

From the VETS, a ratio of COP sway will be used to determine the degree of loss of visual information. Loss of visual information compounds reduced proprioceptive ability in static balance.

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · COP sway ratio
EC FOAM/EO FOAM Ratio
COP sway ratioCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
EC FOAM/EO FOAM Ratio8.43 ± 11.8—
SecondaryDYN FOAM/DYN FIRM Ratio

From the VETS, a ratio of COP sway will be used to determine how roll vection is induced by loss of proprioception.

Time frame:
PostSurgery compared to otherwise healthy Veterans compared to otherwise healthy Veterans
Reported as:
Mean · COP Sway ratio
DYN FOAM/DYN FIRM Ratio
COP Sway ratioCervical Spondylotic Myelopathy (CSM) GroupHealthy Controls
DYN FOAM/DYN FIRM Ratio8.7 ± 13.76—
SecondaryDYN FIRM/ EO FIRM Ratio

From the VETS, a ration of COP sway to determine the degree roll vection is induced.

Time frame:
PreSurgery compared to otherwise healthy Veterans
Reported as:
Mean · COP Sway ratio
DYN FIRM/ EO FIRM Ratio
COP Sway ratioCervical Spondylotic Myelopathy (CSM)Healthy Controls
DYN FIRM/ EO FIRM Ratio6.49 ± 6.62—

Adverse events

Collected over AEs, SAEs, and UAPs were collected from the time of study entry until the end of study participation, and average of 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cervical Spondylotic Myelopathy (CSM)0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Cervical Spondylotic Myelopathy (CSM) Group
Mean63 ± 3.75
Sex: Female, Male
Sex: Female, Male(Participants)Cervical Spondylotic Myelopathy (CSM) Group
Female0
Male6
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Cervical Spondylotic Myelopathy (CSM) Group
Region of Enrollment
Region of Enrollment(Participants)Cervical Spondylotic Myelopathy (CSM) Group
United States6
08

Study locations

1 site
  • Syracuse VA Medical Center, Syracuse, NY
    Syracuse, New York 13210, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 5, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03810781
Lead sponsor
VA Office of Research and Development
Collaborators
Temple University
Responsible party
Sponsor
First posted
Jan 22, 2019
Start date
Feb 7, 2019
Primary completion
Sep 1, 2022
Completion
Sep 1, 2022
Results posted
Dec 15, 2025
Last update
Dec 15, 2025

Study contacts

Richard J. Servatius, PhD
principal investigator · Syracuse VA Medical Center, Syracuse, NY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion